JP2020533437A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020533437A5 JP2020533437A5 JP2020513530A JP2020513530A JP2020533437A5 JP 2020533437 A5 JP2020533437 A5 JP 2020533437A5 JP 2020513530 A JP2020513530 A JP 2020513530A JP 2020513530 A JP2020513530 A JP 2020513530A JP 2020533437 A5 JP2020533437 A5 JP 2020533437A5
- Authority
- JP
- Japan
- Prior art keywords
- polysaccharide
- streptococcus pneumoniae
- immunogenic composition
- unit
- serotype
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000004676 glycans Chemical class 0.000 claims 46
- 229920001282 polysaccharide Polymers 0.000 claims 31
- 239000005017 polysaccharide Substances 0.000 claims 31
- 241000193998 Streptococcus pneumoniae Species 0.000 claims 18
- 229940031000 streptococcus pneumoniae Drugs 0.000 claims 18
- 230000002163 immunogen Effects 0.000 claims 16
- 150000004804 polysaccharides Polymers 0.000 claims 15
- 239000002671 adjuvant Substances 0.000 claims 7
- 102000014914 Carrier Proteins Human genes 0.000 claims 6
- 108010078791 Carrier Proteins Proteins 0.000 claims 6
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 6
- 230000004913 activation Effects 0.000 claims 6
- 108010071134 CRM197 (non-toxic variant of diphtheria toxin) Proteins 0.000 claims 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 5
- 229910052799 carbon Inorganic materials 0.000 claims 5
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 claims 4
- 101800002949 Diphtheria toxin fragment B Proteins 0.000 claims 3
- 229960002885 histidine Drugs 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 claims 3
- 102000004169 proteins and genes Human genes 0.000 claims 3
- 239000011780 sodium chloride Substances 0.000 claims 3
- 229960000814 tetanus toxoid Drugs 0.000 claims 3
- 208000034628 Celiac artery compression syndrome Diseases 0.000 claims 2
- 206010035664 Pneumonia Diseases 0.000 claims 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims 2
- BBWBEZAMXFGUGK-UHFFFAOYSA-N bis(dodecylsulfanyl)-methylarsane Chemical compound CCCCCCCCCCCCS[As](C)SCCCCCCCCCCCC BBWBEZAMXFGUGK-UHFFFAOYSA-N 0.000 claims 2
- 229960003983 diphtheria toxoid Drugs 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 238000000569 multi-angle light scattering Methods 0.000 claims 2
- 239000004094 surface-active agent Substances 0.000 claims 2
- 208000024891 symptom Diseases 0.000 claims 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims 1
- 241000588724 Escherichia coli Species 0.000 claims 1
- 101710082714 Exotoxin A Proteins 0.000 claims 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 claims 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 claims 1
- 201000005702 Pertussis Diseases 0.000 claims 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical group [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims 1
- 229910052782 aluminium Inorganic materials 0.000 claims 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 108010031071 cholera toxoid Proteins 0.000 claims 1
- 230000021615 conjugation Effects 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 230000036039 immunity Effects 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 claims 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023096312A JP2023113922A (ja) | 2017-09-07 | 2023-06-12 | 肺炎球菌多糖体および免疫原性多糖体－キャリアタンパク質コンジュゲートでのその使用 |
| JP2025087103A JP2025128174A (ja) | 2017-09-07 | 2025-05-26 | 肺炎球菌多糖体および免疫原性多糖体－キャリアタンパク質コンジュゲートでのその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762555455P | 2017-09-07 | 2017-09-07 | |
| US62/555,455 | 2017-09-07 | ||
| PCT/US2018/049306 WO2019050814A1 (en) | 2017-09-07 | 2018-09-04 | ANTI-PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC CONJUGATES POLYSACCHARIDE-PROTEIN CARRIER |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023096312A Division JP2023113922A (ja) | 2017-09-07 | 2023-06-12 | 肺炎球菌多糖体および免疫原性多糖体－キャリアタンパク質コンジュゲートでのその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020533437A JP2020533437A (ja) | 2020-11-19 |
| JP2020533437A5 true JP2020533437A5 (enExample) | 2021-08-19 |
Family
ID=65635315
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020513530A Pending JP2020533437A (ja) | 2017-09-07 | 2018-09-04 | 肺炎球菌多糖体および免疫原性多糖体−キャリアタンパク質コンジュゲートでのその使用 |
| JP2023096312A Pending JP2023113922A (ja) | 2017-09-07 | 2023-06-12 | 肺炎球菌多糖体および免疫原性多糖体－キャリアタンパク質コンジュゲートでのその使用 |
| JP2025087103A Withdrawn JP2025128174A (ja) | 2017-09-07 | 2025-05-26 | 肺炎球菌多糖体および免疫原性多糖体－キャリアタンパク質コンジュゲートでのその使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023096312A Pending JP2023113922A (ja) | 2017-09-07 | 2023-06-12 | 肺炎球菌多糖体および免疫原性多糖体－キャリアタンパク質コンジュゲートでのその使用 |
| JP2025087103A Withdrawn JP2025128174A (ja) | 2017-09-07 | 2025-05-26 | 肺炎球菌多糖体および免疫原性多糖体－キャリアタンパク質コンジュゲートでのその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (6) | US11491216B2 (enExample) |
| EP (1) | EP3678655A4 (enExample) |
| JP (3) | JP2020533437A (enExample) |
| KR (2) | KR102783492B1 (enExample) |
| CN (2) | CN117736348A (enExample) |
| AU (2) | AU2018328036B2 (enExample) |
| BR (1) | BR112020004396A8 (enExample) |
| CA (1) | CA3074706A1 (enExample) |
| MX (2) | MX2020002559A (enExample) |
| WO (1) | WO2019050814A1 (enExample) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11160855B2 (en) * | 2014-01-21 | 2021-11-02 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
| SI3096783T1 (sl) | 2014-01-21 | 2021-09-30 | Pfizer Inc. | Kapsularni polisaharidi streptococcus pneumoniae in njihovi konjugati |
| MX2019007910A (es) | 2016-12-30 | 2019-12-05 | Sutrovax Inc | Conjugados de polipeptido-antigeno con aminoacidos no naturales. |
| US11951165B2 (en) | 2016-12-30 | 2024-04-09 | Vaxcyte, Inc. | Conjugated vaccine carrier proteins |
| US20200222550A1 (en) * | 2017-01-31 | 2020-07-16 | Merck Sharp & Dohme Corp. | Methods for production of capsular polysaccharide protein conjugates from streptococcus pneumoniae serotype 19f |
| KR20240169144A (ko) | 2017-01-31 | 2024-12-02 | 머크 샤프 앤드 돔 엘엘씨 | 다당류-단백질 접합체 제조 방법 |
| KR20190121330A (ko) | 2017-02-24 | 2019-10-25 | 머크 샤프 앤드 돔 코포레이션 | 스트렙토코쿠스 뉴모니아에 폴리사카라이드-단백질 접합체의 면역원성의 증진 |
| US11400162B2 (en) | 2017-02-24 | 2022-08-02 | Merck Sharp & Dohme Llc | Processes for the formulation of pneumococcal polysaccharides for conjugation to a carrier protein |
| US10729763B2 (en) | 2017-06-10 | 2020-08-04 | Inventprise, Llc | Mixtures of polysaccharide-protein pegylated compounds |
| US11389540B2 (en) | 2017-09-07 | 2022-07-19 | Merck Sharp & Dohme Llc | Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates |
| AU2018328040B2 (en) | 2017-09-07 | 2025-01-16 | Merck Sharp & Dohme Llc | Processes for the formulation of pneumococcal polysaccharides for conjugation to a carrier protein |
| US11524076B2 (en) | 2017-09-07 | 2022-12-13 | Merck Sharp & Dohme Llc | Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates |
| CA3074706A1 (en) * | 2017-09-07 | 2019-03-14 | Merck Sharp & Dohme Corp. | Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates |
| WO2019050813A1 (en) | 2017-09-07 | 2019-03-14 | Merck Sharp & Dohme Corp. | ANTI-PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC CONJUGATES POLYSACCHARIDE-PROTEIN CARRIER |
| BR112020004509A8 (pt) * | 2017-09-07 | 2023-01-31 | Merck Sharp & Dohme | Conjugado polissacarídeo-proteína carreadora, composição imunogênica compreendendo o mesmo e uso do referido conjugado |
| EP3691677A4 (en) * | 2017-10-04 | 2021-07-07 | Pogona, Llc | COMPOSITIONS OF SACCHARIDE-POLYPEPTIDE CONJUGATES AND THEIR METHODS OF USE |
| BR112020011414B8 (pt) | 2017-12-06 | 2023-01-31 | Merck Sharp & Dohme | Composições imunogênicas multivalentes compreendendo conjugados de proteína carreadora e polissacarídeo de s. pneumoniae |
| US20210252125A1 (en) | 2018-04-30 | 2021-08-19 | Merck Sharp & Dohme Corp. | Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates |
| JP7397000B2 (ja) | 2018-04-30 | 2023-12-12 | メルク・シャープ・アンド・ドーム・エルエルシー | 凍結乾燥変異ジフテリア毒素のジメチルスルホキシド中均一溶液を提供する方法 |
| US12144855B2 (en) | 2018-04-30 | 2024-11-19 | Merck Sharp & Dohme Llc | Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates from lyospheres |
| AU2019341723C1 (en) | 2018-09-23 | 2026-01-22 | Biological E Limited | Purified capsular polysaccharides of Streptococcus pneumoniae |
| EP3897705A2 (en) | 2018-12-19 | 2021-10-27 | Merck Sharp & Dohme Corp. | Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof |
| MX2022010355A (es) * | 2020-02-21 | 2022-09-21 | Pfizer | Purificacion de sacaridos. |
| WO2022169787A1 (en) * | 2021-02-04 | 2022-08-11 | Merck Sharp & Dohme Llc | Lipid nanoparticle adjuvant composition for pneumococcal conjugate vaccines |
| IL321062A (en) | 2022-11-22 | 2025-07-01 | Pfizer | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
| KR20250113501A (ko) | 2022-12-01 | 2025-07-25 | 화이자 인코포레이티드 | 폐렴구균 접합체 백신 제형 |
| TW202527906A (zh) | 2023-09-14 | 2025-07-16 | 美商輝瑞股份有限公司 | 包含經結合之肺炎鏈球菌莢膜醣抗原之佐劑化致免疫性組成物及其用途 |
| WO2025219908A2 (en) | 2024-04-19 | 2025-10-23 | Pfizer Inc. | Media and fermentation methods for polysaccharide production in bacterial cell culture |
Family Cites Families (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2059693C (en) | 1991-01-28 | 2003-08-19 | Peter J. Kniskern | Polysaccharide antigens from streptococcus pneumoniae |
| CA2059692C (en) | 1991-01-28 | 2004-11-16 | Peter J. Kniskern | Pneumoccoccal polysaccharide conjugate vaccine |
| EP2425853A1 (en) * | 2005-04-08 | 2012-03-07 | Wyeth LLC | Multivalent Pneumococcal Polysaccharide-Protein Conjugate Composition |
| US7955605B2 (en) * | 2005-04-08 | 2011-06-07 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| CA2635208C (en) * | 2005-12-28 | 2018-03-20 | The Uab Research Foundation | Streptococcus pneumonia having a capsular polysaccharide repeating unit {>2)glucose 1(1>3) glucose 2 (1>3) rhamnose (1>3)ribitol (5>phosphate} |
| GB0703369D0 (en) * | 2007-02-21 | 2007-03-28 | Health Prot Agency | Compositions Comprising Capsular Polysaccharides and Their Use as Vaccines |
| WO2010014888A2 (en) * | 2008-07-31 | 2010-02-04 | The Gov't Of The U.S.A. As Represented By The Secretary Of The Dept. Of Health & Human Services | Methods of enhancing opsonophagocytosis in response to a pathogen |
| TW201136603A (en) | 2010-02-09 | 2011-11-01 | Merck Sharp & Amp Dohme Corp | 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition |
| PT3170508T (pt) | 2010-06-04 | 2020-01-16 | Wyeth Llc | Formulações de vacinas |
| CA2819366A1 (en) * | 2010-12-10 | 2012-06-14 | Merck Sharp & Dohme Corp. | Novel formulations which mitigate agitation-induced aggregation of immunogenic compositions |
| CN104519910B (zh) * | 2012-03-07 | 2017-05-03 | 诺华股份有限公司 | 肺炎链球菌抗原的含佐剂制剂 |
| DK3421051T3 (da) | 2012-08-16 | 2020-06-22 | Pfizer | Fremgangsmåder til glycokonjugering og sammensætninger |
| CN103623401A (zh) * | 2012-08-23 | 2014-03-12 | 北京科兴中维生物技术有限公司 | 多价肺炎球菌荚膜多糖-蛋白质共轭组合物及其制备方法 |
| SI3096783T1 (sl) * | 2014-01-21 | 2021-09-30 | Pfizer Inc. | Kapsularni polisaharidi streptococcus pneumoniae in njihovi konjugati |
| PT3096785T (pt) * | 2014-01-21 | 2020-10-13 | Pfizer | Composições imunogénicas que compreendem antigénios de sacáridos capsulares conjugados e utilizações das mesmas |
| US11160855B2 (en) | 2014-01-21 | 2021-11-02 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
| CA2939416A1 (en) * | 2014-02-14 | 2015-08-20 | Pfizer Inc. | Immunogenic glycoprotein conjugates |
| EP3177325B1 (en) * | 2014-08-08 | 2020-04-01 | GlaxoSmithKline Biologicals S.A. | Modified host cells and hybrid oligosaccharides for use in bioconjugate production |
| CA2988366C (en) * | 2015-06-08 | 2021-12-07 | Serum Institute Of India Private Ltd. | Methods for improving the adsorption of polysaccharide-protein conjugates and multivalent vaccine formulation obtained thereof. |
| KR102225282B1 (ko) * | 2015-07-21 | 2021-03-10 | 화이자 인코포레이티드 | 접합된 캡슐형 사카라이드 항원을 포함하는 면역원성 조성물, 그를 포함하는 키트 및 그의 용도 |
| JP6024841B1 (ja) * | 2016-01-27 | 2016-11-16 | 株式会社リコー | 照明装置、パターン照射装置およびシステム |
| EP3436061A4 (en) | 2016-03-31 | 2019-12-04 | Liffey Biotech Limited | Saccharide-polypeptide-conjugate compositions and methods of use thereof |
| EP3292131B1 (en) * | 2016-04-14 | 2019-05-01 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Improved preparation of vaccines against streptococcus pneumoniae type 3 |
| GB201610599D0 (en) * | 2016-06-17 | 2016-08-03 | Glaxosmithkline Biologicals Sa | Immunogenic Composition |
| WO2018004628A1 (en) * | 2016-06-30 | 2018-01-04 | Ford Global Technologies, Llc | Systems, methods, and devices for frame-mounted pedal cadence sensor |
| KR20240169144A (ko) | 2017-01-31 | 2024-12-02 | 머크 샤프 앤드 돔 엘엘씨 | 다당류-단백질 접합체 제조 방법 |
| US20200222550A1 (en) | 2017-01-31 | 2020-07-16 | Merck Sharp & Dohme Corp. | Methods for production of capsular polysaccharide protein conjugates from streptococcus pneumoniae serotype 19f |
| KR20190121330A (ko) | 2017-02-24 | 2019-10-25 | 머크 샤프 앤드 돔 코포레이션 | 스트렙토코쿠스 뉴모니아에 폴리사카라이드-단백질 접합체의 면역원성의 증진 |
| WO2018156465A1 (en) | 2017-02-24 | 2018-08-30 | Merck Sharp & Dohme Corp. | Polysaccharide-protein conjugates utilizing diphtheria toxin fragment b as a carrier |
| US11400162B2 (en) * | 2017-02-24 | 2022-08-02 | Merck Sharp & Dohme Llc | Processes for the formulation of pneumococcal polysaccharides for conjugation to a carrier protein |
| KR102701633B1 (ko) | 2017-02-24 | 2024-09-02 | 머크 샤프 앤드 돔 엘엘씨 | 폐렴구균 접합체 백신 제제 |
| WO2018156467A1 (en) | 2017-02-24 | 2018-08-30 | Merck Sharp & Dohme Corp. | Methods for improving filterability of polysaccharide-protein conjugate reactions |
| MD20190088A2 (ro) * | 2017-05-05 | 2020-04-30 | Serum Institute Of India Private Limited | Metodă de eliminare a impurităţilor din preparatele pe bază de polizaharide capsulare bacteriene |
| GB201711635D0 (en) * | 2017-07-19 | 2017-08-30 | Glaxosmithkline Biologicals Sa | Immunogenic composition |
| GB201711637D0 (en) * | 2017-07-19 | 2017-08-30 | Glaxosmithkline Biologicals Sa | Immunogenic composition |
| US20200360500A1 (en) | 2017-08-16 | 2020-11-19 | Merck Sharp & Dohme Corp. | Pneumococcal conjugate vaccine formulations |
| US11524076B2 (en) * | 2017-09-07 | 2022-12-13 | Merck Sharp & Dohme Llc | Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates |
| AU2018328040B2 (en) | 2017-09-07 | 2025-01-16 | Merck Sharp & Dohme Llc | Processes for the formulation of pneumococcal polysaccharides for conjugation to a carrier protein |
| US11389540B2 (en) * | 2017-09-07 | 2022-07-19 | Merck Sharp & Dohme Llc | Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates |
| WO2019050813A1 (en) * | 2017-09-07 | 2019-03-14 | Merck Sharp & Dohme Corp. | ANTI-PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC CONJUGATES POLYSACCHARIDE-PROTEIN CARRIER |
| CA3074706A1 (en) | 2017-09-07 | 2019-03-14 | Merck Sharp & Dohme Corp. | Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates |
| BR112020004509A8 (pt) | 2017-09-07 | 2023-01-31 | Merck Sharp & Dohme | Conjugado polissacarídeo-proteína carreadora, composição imunogênica compreendendo o mesmo e uso do referido conjugado |
| KR20200077538A (ko) | 2017-10-25 | 2020-06-30 | 머크 샤프 앤드 돔 코포레이션 | 아주반트 첨가된 백신 |
| BR112020011414B8 (pt) * | 2017-12-06 | 2023-01-31 | Merck Sharp & Dohme | Composições imunogênicas multivalentes compreendendo conjugados de proteína carreadora e polissacarídeo de s. pneumoniae |
| US12144855B2 (en) * | 2018-04-30 | 2024-11-19 | Merck Sharp & Dohme Llc | Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates from lyospheres |
| EP3897705A2 (en) * | 2018-12-19 | 2021-10-27 | Merck Sharp & Dohme Corp. | Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof |
| AU2020315673B2 (en) * | 2019-07-18 | 2025-01-23 | Celltrion, Inc. | Immunogenic composition comprising multivalent Streptococcus pneumoniae polysaccharide-protein conjugates |
| EP4192499A4 (en) * | 2020-08-10 | 2024-09-25 | Inventprise, Inc. | Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24f |
-
2018
- 2018-09-04 CA CA3074706A patent/CA3074706A1/en active Pending
- 2018-09-04 BR BR112020004396A patent/BR112020004396A8/pt unknown
- 2018-09-04 AU AU2018328036A patent/AU2018328036B2/en active Active
- 2018-09-04 MX MX2020002559A patent/MX2020002559A/es unknown
- 2018-09-04 WO PCT/US2018/049306 patent/WO2019050814A1/en not_active Ceased
- 2018-09-04 EP EP18854598.2A patent/EP3678655A4/en active Pending
- 2018-09-04 KR KR1020207009613A patent/KR102783492B1/ko active Active
- 2018-09-04 CN CN202311711412.1A patent/CN117736348A/zh active Pending
- 2018-09-04 CN CN201880058250.7A patent/CN111065388A/zh active Pending
- 2018-09-04 JP JP2020513530A patent/JP2020533437A/ja active Pending
- 2018-09-04 US US16/645,048 patent/US11491216B2/en active Active
- 2018-09-04 KR KR1020257008384A patent/KR20250046326A/ko active Pending
-
2020
- 2020-03-05 MX MX2022014850A patent/MX2022014850A/es unknown
-
2022
- 2022-09-22 US US17/934,379 patent/US20230075760A1/en active Pending
- 2022-09-22 US US17/934,396 patent/US20230107713A1/en active Pending
- 2022-09-27 US US17/935,864 patent/US20230041441A1/en active Pending
- 2022-09-27 US US17/935,856 patent/US20230094548A1/en active Pending
- 2022-09-27 US US17/935,871 patent/US20230029424A1/en active Pending
-
2023
- 2023-06-12 JP JP2023096312A patent/JP2023113922A/ja active Pending
-
2024
- 2024-03-06 AU AU2024201479A patent/AU2024201479A1/en not_active Abandoned
-
2025
- 2025-05-26 JP JP2025087103A patent/JP2025128174A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020533438A5 (enExample) | ||
| JP2020533442A5 (enExample) | ||
| JP7132954B2 (ja) | 改善された免疫原性及び結合活性を提供する２価又は多価コンジュゲート多糖を含む多価コンジュゲートワクチン | |
| Khatun et al. | An overview of structural features of antibacterial glycoconjugate vaccines that influence their immunogenicity | |
| JP2020533439A5 (enExample) | ||
| IL276230B2 (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
| JP2025128174A5 (enExample) | ||
| IL276229B2 (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
| RU2634405C2 (ru) | Иммуногенная композиция | |
| HRP20120278T1 (hr) | Polivalentni pripravak konjugata pneumokoknog polisaharida s proteinom | |
| HRP20110685T1 (hr) | Cjepivo od konjugata pneumokoknog polisaharida | |
| HRP20190198T4 (hr) | Formulacije koje stabiliziraju i inhibiraju taloženje imunogenih pripravaka | |
| HRP20211288T1 (hr) | Kapsularni polisaharidi bakterije streptococcus pneumoniae i njihovi konjugati | |
| TW201718005A (zh) | 包含經共軛之莢膜糖抗原的致免疫性組成物、包含該致免疫性組成物之套組及彼等之用途 | |
| US12251438B2 (en) | Immunogenic compositions of polysaccharide-protein pegylated compounds | |
| CN113164581A (zh) | 纯化的肺炎链球菌荚膜多糖 | |
| BR112020021296A2 (pt) | polissacarídeo capsular de streptococcus pneumoniae e conjugado imunogênico do mesmo | |
| US20240000958A1 (en) | Novel carriers and conjugation methods | |
| Zou et al. | Preparation of glycoconjugate vaccines | |
| RU2020112312A (ru) | Пневмококковые полисахариды и их применение в иммуногенных конъюгатах полисахарид-белок-носитель | |
| RU2020112314A (ru) | Пневмококковые полисахариды и их применение в иммуногенных конъюгатах полисахарид-белок-носитель | |
| RU2022129006A (ru) | Пневмококковые полисахариды и их применение в иммуногенных конъюгатах полисахарид-белок-носитель | |
| RU2020112309A (ru) | Пневмококковые полисахариды и их применение в иммуногенных конъюгатах полисахарид-белок-носитель | |
| RU2023120100A (ru) | Пневмококковые полисахариды и их применение в иммуногенных конъюгатах полисахарид-белок-носитель | |
| RU2020112308A (ru) | Пневмококковые полисахариды и их применение в иммуногенных конъюгатах полисахарид-белок-носитель |